Skip to main content

CITADEL ADVISORS LLC

Position in BIVI — Biovie Inc.

CIK 1423053 MIAMI, FL

Position in BIVI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$186,146
+$122,738 QoQ
Shares Held
95,952
+111.9% QoQ
Ownership
1.27%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 36 holders
Holding Since
Dec 2022
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BIVI Over Time

Shares Held

Position Value (USD)

Derivatives in BIVI

reported options exposure · as of Jun 30, 2024
CallValue
$6,897
CallShares
172
PutValue
$4,290
PutShares
107

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,175,465,875 across 436 Biotechnology names. BIVI ranks #324 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BIVI

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $186,146 95,952
2026-03-31 $63,408 45,292
2025-12-31 $21,054 18,150
2025-09-30 $198,608 104,531
2024-06-30 $6,897 17,200
2024-06-30 $4,290 10,700
2024-03-31 $23,487 44,400
2024-03-31 $27,349 51,700
2023-12-31 $124,488 98,800
2023-12-31 $35 28
2023-12-31 $5,040 4,000
2023-09-30 $22,165 6,500
2023-09-30 $27,532 8,074
2023-09-30 $87,637 25,700
2023-06-30 $106,888 24,800
2023-06-30 $69,391 16,100
2023-03-31 $173,720 21,500
2023-03-31 $83,224 10,300
2023-03-31 $12,863 1,592
2022-12-31 $118,080 15,197